FDA Update

FDA Request for Advisory Committee Nominations: Consumer Organizations and Individuals

The Food and Drug Administration seeks input from consumers on medical and scientific issues. A key method of ensuring that FDA obtains the points of view of consumers is by including Consumer Representatives on Agency advisory committees.  The FDA, relies on their many advisory committees to help them make sound decisions based on the best science available. Advisory committee meetings can include a broad scientific discussion about important topics, such as the development of vaccines for COVID-19. They can also be more focused on a specific product under FDA review. FDA is requesting nominations for voting and/or nonvoting consumer representatives to serve on advisory committees and/or panels for which vacancies currently exist or are expected to occur in the near future. For advisory committee vacancies listed in this notice, and those that may occur through December 31, 2023:

Consumer organizations:
Consumer organizations interested in participating in the selection of an appropriate voting or nonvoting member to represent consumer interests on an FDA advisory committee or panel may send a letter or email (to [email protected]) stating that interest to FDA by August 15, 2022.

Consumer representatives:
Nominees recommended to serve as a voting or nonvoting consumer representative may be self-nominated or may be nominated by a consumer organization. FDA seeks to include the views of individuals on its advisory committee regardless of their gender identification, religious affiliation, racial and ethnic identification, or disability status and, therefore, encourages nominations of appropriately qualified candidates from all groups. Consumer representative nominations should be submitted electronically through the FDA Advisory Committee Membership Nomination Portal, by August 15, 2022.

Alternatively, materials may be submitted by mail at the addresses noted in the Federal Register notice.

For more information on the FDA expectations for Advisory Committee Nominations, please email us at: [email protected] and ref: Advisory Committee Nominations.